2017 Q1 Form 10-Q Financial Statement
#000114420417024606 Filed on May 04, 2017
Income Statement
| Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
|---|---|---|---|
| Revenue | $38.83M | $7.779M | $28.17M |
| YoY Change | 37.86% | 6.56% | 27.44% |
| Cost Of Revenue | $26.36M | $6.750M | $20.65M |
| YoY Change | 27.7% | 13.83% | 24.53% |
| Gross Profit | $12.47M | $1.033M | $7.522M |
| YoY Change | 65.74% | -24.49% | 36.14% |
| Gross Profit Margin | 32.11% | 13.28% | 26.71% |
| Selling, General & Admin | $2.952M | $3.270M | $2.503M |
| YoY Change | 17.94% | 4.81% | 11.0% |
| % of Gross Profit | 23.68% | 316.55% | 33.28% |
| Research & Development | |||
| YoY Change | |||
| % of Gross Profit | |||
| Depreciation & Amortization | $483.0K | $510.0K | $606.0K |
| YoY Change | -20.3% | 13.33% | 11.4% |
| % of Gross Profit | 3.87% | 49.37% | 8.06% |
| Operating Expenses | $3.074M | $3.267M | $2.503M |
| YoY Change | 22.81% | 4.71% | 11.0% |
| Operating Profit | $9.393M | -$2.234M | $5.019M |
| YoY Change | 87.15% | 27.51% | 53.49% |
| Interest Expense | $85.00K | -$200.0K | -$270.0K |
| YoY Change | -131.48% | 11.11% | -230.43% |
| % of Operating Profit | 0.9% | -5.38% | |
| Other Income/Expense, Net | -$85.00K | -$763.0K | -$271.0K |
| YoY Change | -68.63% | -705.56% | 30.92% |
| Pretax Income | $9.308M | -$2.997M | $4.748M |
| YoY Change | 96.04% | 84.32% | 55.01% |
| Income Tax | $3.574M | -$1.071M | $1.804M |
| % Of Pretax Income | 38.4% | 37.99% | |
| Net Earnings | $5.734M | -$1.926M | $2.944M |
| YoY Change | 94.77% | 88.27% | 55.52% |
| Net Earnings / Revenue | 14.77% | -24.76% | 10.45% |
| Basic Earnings Per Share | $0.14 | -$0.05 | $0.09 |
| Diluted Earnings Per Share | $0.13 | -$0.05 | $0.09 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 41.51M | 36.53M shares | 32.89M shares |
| Diluted Shares Outstanding | 43.50M | 36.53M shares | 33.94M shares |
Balance Sheet
| Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $40.20M | $33.90M | $1.200M |
| YoY Change | 3250.0% | 2507.69% | 140.0% |
| Cash & Equivalents | $40.16M | $33.93M | $1.167M |
| Short-Term Investments | |||
| Other Short-Term Assets | $6.300M | $800.0K | $4.100M |
| YoY Change | 53.66% | -57.89% | 173.33% |
| Inventory | $72.40M | $68.60M | $55.30M |
| Prepaid Expenses | |||
| Receivables | $20.70M | $4.800M | $15.80M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $139.5M | $108.2M | $76.40M |
| YoY Change | 82.59% | 55.72% | 47.78% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $7.400M | $7.532M | $7.200M |
| YoY Change | 2.78% | -0.05% | -6.49% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | |||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $2.100M | $75.00K | $1.600M |
| YoY Change | 31.25% | -1.32% | -68.0% |
| Total Long-Term Assets | $13.60M | $14.32M | $13.30M |
| YoY Change | 2.26% | -7.84% | -29.7% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $139.5M | $108.2M | $76.40M |
| Total Long-Term Assets | $13.60M | $14.32M | $13.30M |
| Total Assets | $153.1M | $122.5M | $89.70M |
| YoY Change | 70.68% | 44.1% | 27.02% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $29.00M | $5.100M | $3.800M |
| YoY Change | 663.16% | -12.07% | -56.32% |
| Accrued Expenses | $2.400M | $4.700M | $2.900M |
| YoY Change | -17.24% | 2.17% | 383.33% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $199.0K | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $100.0K | $0.00 | $26.10M |
| YoY Change | -99.62% | -100.0% | 183.7% |
| Total Short-Term Liabilities | $34.96M | $10.30M | $32.90M |
| YoY Change | 6.26% | -66.73% | 78.53% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $129.0K | $152.0K | $4.200M |
| YoY Change | -96.93% | -96.46% | -2.73% |
| Other Long-Term Liabilities | $0.00 | $0.00 | |
| YoY Change | -100.0% | -100.0% | |
| Total Long-Term Liabilities | $129.0K | $152.0K | $4.200M |
| YoY Change | -96.93% | -96.71% | -31.72% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $34.96M | $10.30M | $32.90M |
| Total Long-Term Liabilities | $129.0K | $152.0K | $4.200M |
| Total Liabilities | $35.09M | $10.45M | $37.10M |
| YoY Change | -5.42% | -70.63% | 50.94% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $3.304M | -$2.430M | -$10.12M |
| YoY Change | -132.64% | -81.4% | -36.48% |
| Common Stock | |||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | $118.0M | $112.0M | $52.66M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $153.1M | $122.5M | $89.73M |
| YoY Change | 70.63% | 44.06% | 27.07% |
Cashflow Statement
| Concept | 2017 Q1 | 2016 Q4 | 2016 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $5.734M | -$1.926M | $2.944M |
| YoY Change | 94.77% | 88.27% | 55.52% |
| Depreciation, Depletion And Amortization | $483.0K | $510.0K | $606.0K |
| YoY Change | -20.3% | 13.33% | 11.4% |
| Cash From Operating Activities | $6.943M | $1.910M | -$5.720M |
| YoY Change | -221.38% | -138.2% | 606.17% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | $369.0K | -$850.0K | $133.0K |
| YoY Change | 177.44% | 240.0% | 125.42% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | $0.00 | $0.00 | |
| YoY Change | -100.0% | ||
| Cash From Investing Activities | -$369.0K | -$850.0K | -$130.0K |
| YoY Change | 183.85% | 240.0% | -94.76% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | $267.0K | $278.0K | |
| YoY Change | -3.96% | 297.14% | |
| Debt Paid & Issued, Net | $85.00K | $93.00K | |
| YoY Change | -8.6% | 30.99% | |
| Cash From Financing Activities | -$346.0K | 28.91M | 5.770M |
| YoY Change | -106.0% | 428.52% | 104.61% |
| NET CHANGE | |||
| Cash From Operating Activities | $6.943M | 1.910M | -5.720M |
| Cash From Investing Activities | -$369.0K | -850.0K | -130.0K |
| Cash From Financing Activities | -$346.0K | 28.91M | 5.770M |
| Net Change In Cash | $6.228M | 29.97M | -80.00K |
| YoY Change | -7885.0% | 13522.73% | -82.98% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $6.943M | $1.910M | -$5.720M |
| Capital Expenditures | $369.0K | -$850.0K | $133.0K |
| Free Cash Flow | $6.574M | $2.760M | -$5.853M |
| YoY Change | -212.32% | -158.11% | 573.53% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2017Q1 | us-gaap |
Liabilities
Liabilities
|
35089000 | USD |
| CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
10453000 | USD |
| CY2017Q1 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2016Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
| CY2017Q1 | us-gaap |
Gross Profit
GrossProfit
|
12467000 | USD |
| CY2017Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2017Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
26363000 | USD |
| CY2017Q1 | us-gaap |
Operating Expenses
OperatingExpenses
|
3074000 | USD |
| CY2017Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
9393000 | USD |
| CY2017Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
3574000 | USD |
| CY2017Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
5734000 | USD |
| CY2017Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.14 | |
| CY2017Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.13 | |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
41507941 | shares |
| CY2017Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
43503889 | shares |
| CY2016Q1 | us-gaap |
Revenues
Revenues
|
28167000 | USD |
| CY2016Q1 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
20645000 | USD |
| CY2016Q1 | us-gaap |
Gross Profit
GrossProfit
|
7522000 | USD |
| CY2016Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
1117000 | USD |
| CY2016Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1386000 | USD |
| CY2017Q1 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
114299000 | USD |
| CY2016Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
114032000 | USD |
| CY2017Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
118018000 | USD |
| CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
112017000 | USD |
| CY2017Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
153107000 | USD |
| CY2017Q1 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
3400000 | USD |
| CY2016Q4 | us-gaap |
Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
|
322000 | USD |
| CY2017Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
3304000 | USD |
| CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-2430000 | USD |
| CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
122470000 | USD |
| CY2016Q4 | us-gaap |
Debt Current
DebtCurrent
|
199000 | USD |
| CY2017Q1 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
34960000 | USD |
| CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
10301000 | USD |
| CY2017Q1 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
129000 | USD |
| CY2016Q4 | us-gaap |
Long Term Debt Noncurrent
LongTermDebtNoncurrent
|
152000 | USD |
| CY2017Q1 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
29016000 | USD |
| CY2016Q4 | us-gaap |
Accounts Payable Trade Current
AccountsPayableTradeCurrent
|
5110000 | USD |
| CY2017Q1 | us-gaap |
Debt Current
DebtCurrent
|
138000 | USD |
| CY2017Q1 | us-gaap |
Revenues
Revenues
|
38830000 | USD |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1387000 | USD |
| CY2016Q1 | us-gaap |
Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
|
-91000 | USD |
| CY2016Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1167000 | USD |
| CY2016Q1 | us-gaap |
Interest Paid
InterestPaid
|
241000 | USD |
| CY2016Q1 | hdsn |
Payment Of Deferred Acquisition Cost
PaymentOfDeferredAcquisitionCost
|
0 | USD |
| CY2017Q1 | us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
85000 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
-346000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
3266000 | USD |
| CY2017Q1 | us-gaap |
Interest Paid
InterestPaid
|
89000 | USD |
| CY2017Q1 | hdsn |
Payment Of Deferred Acquisition Cost
PaymentOfDeferredAcquisitionCost
|
528000 | USD |
| CY2016Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
40000 | USD |
| CY2016Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
11000 | USD |
| CY2016Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
31000 | USD |
| CY2016Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
11466000 | USD |
| CY2016Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-6613000 | USD |
| CY2016Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
2229000 | USD |
| CY2016Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-3998000 | USD |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-5723000 | USD |
| CY2016Q1 | us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
5580000 | USD |
| CY2016Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
5765000 | USD |
| CY2016Q1 | us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
0 | USD |
| CY2015Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
1258000 | USD |
| CY2017Q1 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
2000000 | USD |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
2500000 | USD |
| CY2016Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
1064000 | shares |
| CY2017Q1 | us-gaap |
Depreciation
Depreciation
|
500000 | USD |
| CY2016Q1 | us-gaap |
Depreciation
Depreciation
|
500000 | USD |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
4686000 | USD |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
4686000 | USD |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1509000 | USD |
| CY2017Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
605000 | USD |
| CY2017Q1 | us-gaap |
Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
|
30000 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
0 | USD |
| CY2017Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
16000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
15964000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
3751000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
5471000 | USD |
| CY2017Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
22171000 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
6943000 | USD |
| CY2017Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
369000 | USD |
| CY2017Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-369000 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
267000 | USD |
| CY2017Q1 | us-gaap |
Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
|
0 | USD |
| CY2017Q1 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3177000 | USD |
| CY2016Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
3299000 | USD |
| CY2017Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
100000 | USD |
| CY2016Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
100000 | USD |
| CY2016Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
11000 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
|
6000000 | shares |
| CY2017Q1 | us-gaap |
Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
|
3251340 | shares |
| CY2015 | us-gaap |
Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
|
1000000 | USD |
| CY2015 | hdsn |
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Goodwill
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwill
|
1900000 | USD |
| CY2015 | us-gaap |
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Intangibles
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentIntangibles
|
800000 | USD |
| CY2015 | us-gaap |
Business Combination Provisional Information Initial Accounting Incomplete Adjustment Inventory
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentInventory
|
100000 | USD |
| CY2015Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
|
1600000 | USD |
| CY2015Q1 | us-gaap |
Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
|
1600000 | USD |
| CY2015Q1 | us-gaap |
Business Acquisition Purchase Price Allocation Goodwill Expected Tax Deductible Amount
BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount
|
2300000 | USD |
| CY2013Q1 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
40000000 | USD |
| CY2012Q2 | us-gaap |
Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
|
50000000 | USD |
| CY2016Q4 | us-gaap |
Line Of Credit Facility Current Borrowing Capacity
LineOfCreditFacilityCurrentBorrowingCapacity
|
50000000 | USD |
| CY2017Q1 | us-gaap |
Letters Of Credit Outstanding Amount
LettersOfCreditOutstandingAmount
|
130000 | USD |
| CY2017Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2017Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2016Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
| CY2017Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
41539181 | shares |
| CY2017Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
41539181 | shares |
| CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
41465820 | shares |
| CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
41465820 | shares |
| CY2017Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
307000 | USD |
| CY2016Q1 | us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
1725000 | USD |
| CY2017Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Credit Risk</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company's trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer's credit history before extending credit.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">   </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">For the three month period ended March 31, 2017, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>two customers each accounted for 10% or more of the Company’s revenues <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 39</font>% of the Company’s revenues. At March 31, 2017, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">4.7</font> million in outstanding receivables from these customers.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">For the three month period ended March 31, 2016, <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>two customers each accounted for 10% or more of the Company’s revenues <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>and, in the aggregate these two customers accounted for <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 44</font>% of the Company’s revenues. At March 31, 2016, there were $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">5.1</font> million in outstanding receivables from these customers.</font></div> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company's products or services by any such customer could have a material adverse effect on the Company's operating results and financial position.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Estimates and Risks</font></strong></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect reported amounts of certain assets and liabilities, the disclosure of contingent assets and liabilities, and the results of operations during the reporting period. Actual results could differ from these estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="center"><font style="FONT-SIZE: 10pt">   </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Several of the Company's accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management's judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;CLEAR: both"> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company participates in an industry that is highly regulated, and changes in the regulations affecting our business could affect our operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. Effective January 1, 1996, the Clean Air Act (the “Act”) prohibited the production of virgin CFC refrigerants and limited the production of virgin HCFC refrigerants. Effective January 2004, the Act further limited the production of virgin HCFC refrigerants and federal regulations were enacted which established production and consumption allowances for HCFC refrigerants which imposed limitations on the importation of certain virgin HCFC refrigerants. Under the Act, production of certain virgin HCFC refrigerants is scheduled to be phased out during the period 2010 through 2020, and production of all virgin HCFC refrigerants is scheduled to be phased out by 2030. In October 2014, the EPA published a final rule providing further reductions in the production and consumption allowances for virgin HCFC refrigerants for the years 2015 through 2019 (the “Final Rule”). In the Final Rule, the EPA has established a linear draw down for the production or importation of virgin HCFC-22 that started at approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>22 million pounds in 2015 and reduces by approximately 4.5 million pounds each year and ends at zero in 2020.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font> In October 2016, more than 200 countries, including the United States, agreed to amend the Montreal Protocol to phase down production of HFCs by <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 85</font>% between now and 2047. The amendment establishes timetables for all developed and developing countries to freeze and then reduce production and use of HFCs, with the first reductions by developed countries starting in 2019.</font></div> </div> <font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position.</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"> </font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | |
| CY2017Q1 | us-gaap |
Concentration Risk Customer
ConcentrationRiskCustomer
|
two customers each accounted for 10% or more of the Companys revenues | |
| CY2016Q1 | us-gaap |
Concentration Risk Customer
ConcentrationRiskCustomer
|
two customers each accounted for 10% or more of the Companys revenues | |
| CY2017Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
0 | shares |
| CY2017Q1 | hdsn |
Production And Importation Permission Description
ProductionAndImportationPermissionDescription
|
22 million pounds in 2015 and reduces by approximately 4.5 million pounds each year and ends at zero in 2020. | |
| CY2016Q4 | hdsn |
Production Phase Down Percentage
ProductionPhaseDownPercentage
|
0.85 | pure |
| CY2016Q4 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
2532000 | USD |
| CY2017Q1 | us-gaap |
Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
|
All the Companys remaining NOLs of approximately $4.1 million are subject to annual limitations of $1.3 million. | |
| CY2017Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
22331000 | USD |
| CY2016Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
21983000 | USD |
| CY2017Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
14913000 | USD |
| CY2016Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
14451000 | USD |
| CY2015Q1 | hdsn |
Business Acquisition Purchase Price Allocation Description
BusinessAcquisitionPurchasePriceAllocationDescription
|
The purchase price for this acquisition was $2.4 million cash paid at closing and the assumption of a liability of $20,000, and a maximum of an additional $3.0 million earn-out | |
| CY2015Q4 | us-gaap |
Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High
BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
|
3000000 | USD |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
|
3141037 | shares |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
|
2.66 | |
| CY2017Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
|
P2Y2M12D | |
| CY2017Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
260747 | USD |
| CY2016Q1 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
|
253000 | USD |
| CY2017Q1 | hdsn |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue
|
12400000 | USD |
| CY2016 | hdsn |
Share Based Compensation Arrangement By Share Based Payment Award Options Vested In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedInPeriodTotalIntrinsicValue
|
17100000 | USD |
| CY2017Q1 | us-gaap |
Line Of Credit Facility Interest Rate Description
LineOfCreditFacilityInterestRateDescription
|
Interest charges with respect to loans are computed on the actual principal amount of loans outstanding during the month at a rate per annum equal to (A) with respect to Domestic Rate Loans (as defined in the PNC Facility), the sum of the Alternate Base Rate (as defined in the PNC Facility) plus one half of one percent (.50%) and (B) with respect to Eurodollar Rate Loans, the sum of the Eurodollar Rate plus two and one quarter of one percent (2.25%). | |
| CY2017Q1 | us-gaap |
Line Of Credit Facility Expiration Date1
LineOfCreditFacilityExpirationDate1
|
2020-06-30 | |
| CY2017Q1 | us-gaap |
Deferred Tax Assets Net Current
DeferredTaxAssetsNetCurrent
|
2036000 | USD |
